Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits

Endocrine Journal

Volumn 61, Issue 7, 2014, Pages 683-689

  Kitamoto, Aya ^a   Kitamoto, Takuya ^a   Nakamura, Takahiro ^b   Ogawa, Yuji ^c   Yoneda, Masato ^c   Hyogo, Hideyuki ^d   Ochi, Hidenori ^d   Mizusawa, Seiho ^a   Ueno, Takato ^e   Nakao, Kazuwa ^a   Sekine, Akihiro ^a   Chayama, Kazuaki ^d   Nakajima, Atsushi ^c   Hotta, Kikuko ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e KURUME UNIVERSITY   (Japan)

Author keywords

GCKR; Japanese; Metabolic syndrome; Nonalcoholic fatty liver disease; TRIB1

Indexed keywords

ADIPONUTRIN, HUMAN; GCKR PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRIACYLGLYCEROL LIPASE; TRIB1 PROTEIN, HUMAN;

ADULT; ALLELE; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; COMPLICATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; JAPAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; LIPASE; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; SEVERITY OF ILLNESS INDEX;

EID: 84905187459     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0052     Document Type: Article

References (32)

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
2. Farrell GC (2003) Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 18: 124-138.
3. Okanoue T, Umemura A, Yasui K, Itoh Y (2011) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol g Suppl 1: 153-162.
4. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438.
5. Anstee QM, Day CP (2013) The genetics of NAFLD. Nat Rev Gastroenterol Hepatol 10: 645-655.
6. Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, et al. (2008) Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol 8: 27.
7. Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, et al. (2009) Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalco holic fatty liver disease. Liver Int 29: 1078-1085.
8. Yoneda M, Hotta K, Nozaki Y, Endo H, Tomeno W, et al. (2009) Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease. Hepatol Res 39: 963-971.
9. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, et al. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-1465.
10. Chalasani N, Guo X, Loomba R, Goodarzi MO, Haritunians T, et al. (2010) Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology 139: 1567-1576.
11. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, et al. (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 7: e1001324.
12. Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, et al. (2012) Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One 7: e38322.
13. Hotta K, Yoneda M, Hyogo H, Ochi H, Mizusawa S, et al. (2010) Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet 11: 172.
14. Kitamoto T, Kitamoto A, Yoneda M, Hyogo H, Ochi H, et al. (2013) Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet 132: 783-792.
15. Yuan X, Waterworth D, Perry JR, Lim N, Song K, et al. (2008) Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 83: 520-528.
16. Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, et al. (2011) Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 43: 1131-1138.
17. Feitosa MF, Wojczynski MK, North KE, Zhang Q, Province MA, et al. (2013) The ERLIN1-CHUKCWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study. Atherosclerosis 228: 175-180.
18. Sanyal AJ (2002) American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725.
19. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, et al. (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419.
20. Teli MR, James OF, Burt AD, Bennett MK, Day CP (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22: 1714-1719.
21. Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21: 3-16.
22. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
23. Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, et al. (1999) Abdominal fat: standardized technique for measurement at CT. Radiology 211: 283-286.
24. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, et al. (2001) A high-throughput SNP typing system for genomewide association studies. J Hum Genet 46: 471-477.
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
26. Sookoian S, Pirola CJ (2011) Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53: 1883-1894.
27. Zain SM, Mohamed R, Mahadeva S, Cheah PL, Rampal S, et al. (2012) A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in nonalcoholic fatty liver disease. Hum Genet 131: 1145-1152.
28. Palmer ND, Musani SK, Yerges-Armstrong LM, Feitosa MF, Bielak LF, et al. (2013) Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. Hepatology 58: 966-975.
29. Hernaez R, McLean J, Lazo M, Brancati FL, Hirschhorn JN, et al. (2013) Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third national health and nutrition examination survey. Clin Gastroenterol Hepatol 11: 1183-1190.
30. Tan HL, Zain SM, Mohamed R, Rampal S, Chin KF, et al. (2013) Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene. J Gastroenterol in press (doi:10.1007/s00535-013- 0850-x).
31. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF, et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
32. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, et al. (2008) Six new loci associated with blood lowdensity lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40: 189-197.